Biotech
0 stories from 0 sources this week
More headlines
- Vir Biotechnology appoints Brent Sabatini Interim CFOVir Biotechnology named Brent Sabatini as interim principal financial officer after Jason O’Byrne’s departure, with O’Byrne remaining through August 3 to ensure a smooth transition and a search for a permanent CFO underway. Sabatini, currently SVP and Chief Accounting Officer, brings more than two decades of finance and accounting experience and is expected to maintain continuity in financial oversight during the leadership change.6 src · Jul 24, 2026
- CNTN completes Gravitas sale, refocuses strategyCanton Strategic Holdings completed the sale of its Gravitas Life Sciences biotech unit to Gravitas Collective Corp, a deal approved by a special independent committee and closed in mid-July 2026, shifting the company away from biotech toward its Canton Network and digital-asset initiatives. The move aims to streamline operations, boost focus on digital assets and GV104, and is complemented by governance safeguards and a renewed emphasis on blockchain infrastructure, with insiders having minimal recent activity on the stock.5 src · Jul 23, 2026
You're all caught up.